Cold Sores Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Conditions:   Cervical Cancer;   Endometrial Cancer;   Advanced Cancer Intervention:   Drug: Recombinant oncolytic herpes simplex virus type Ⅰ (R130) Sponsors:   Shanghai Yunying Medical Technology;   Shanghai 10th People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials